← Back to Search

Cementless Knee Replacement for Osteoarthritis

N/A
Waitlist Available
Research Sponsored by DePuy Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject was diagnosed with NIDJD
Subject is male or female and between the ages of 22 and 80 years at the time of surgery, inclusive
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre-op (-90 to -1 days before surgery), 6 weeks (1-90 days after surgery), 6 months (91-303 days after surgery), minimum 1 year (304-669 days after surgery), minimum 2 years (670-1033 days after surgery), minimum 5 years (1764-2190 days after surgery)
Awards & highlights

Study Summary

This trial will compare two types of cementless TKA RP systems to see which results in better functional performance as measured by the KOOS questionnaire.

Who is the study for?
This trial is for men and women aged 22-80 who are not bedridden, can consent to the study, understand procedures, complete questionnaires in English or translations provided, diagnosed with non-inflammatory degenerative joint disease (NIDJD), and suitable for cementless knee replacement. Exclusions include recent participation in other trials, litigation involvement, inflammatory arthritis conditions, life expectancy under five years, pregnancy/lactation status among others.Check my eligibility
What is being tested?
The ATTUNE Cementless Total Knee Arthroplasty (TKA) system's performance is being tested. Specifically looking at functional improvements two years after surgery using the KOOS questionnaire. It compares cruciate retaining rotating platform and posterior stabilized rotating platform configurations of the TKA system.See study design
What are the potential side effects?
While specific side effects are not listed here for this surgical intervention trial involving a cementless knee prosthesis system like ATTUNE TKA RP systems generally may have risks including pain at the site of surgery, infection risk post-operation, blood clots formation potential in legs or lungs.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a non-inflammatory joint disease.
Select...
I am between 22 and 80 years old.
Select...
I am not confined to bed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre-op (-90 to -1 days before surgery), 6 weeks (1-90 days after surgery), 6 months (91-303 days after surgery), minimum 1 year (304-669 days after surgery), minimum 2 years (670-1033 days after surgery), minimum 5 years (1764-2190 days after surgery)
This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-op (-90 to -1 days before surgery), 6 weeks (1-90 days after surgery), 6 months (91-303 days after surgery), minimum 1 year (304-669 days after surgery), minimum 2 years (670-1033 days after surgery), minimum 5 years (1764-2190 days after surgery) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient-reported Outcome: Knee Injury and Osteoarthritis Outcome Score Activities of Daily Living (KOOS ADL)
Secondary outcome measures
Combination of Patient-reported and Clinical-reported Outcome: Knee Society 2011
Evaluate changes in femoral component and tibial component alignment
Implant fixation: Radiographic assessment of bone-implant interface performance
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: ATTUNE Cementless RP TKAExperimental Treatment1 Intervention
Subjects will receive a cementless, rotating platform total knee arthroplasty
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cementless Total Knee Arthroplasty
2017
N/A
~90

Find a Location

Who is running the clinical trial?

DePuy OrthopaedicsLead Sponsor
79 Previous Clinical Trials
25,299 Total Patients Enrolled
44 Trials studying Osteoarthritis
10,373 Patients Enrolled for Osteoarthritis
Sukhjeet KaurStudy DirectorSponsor GmbH
1 Previous Clinical Trials
400 Total Patients Enrolled

Media Library

Cementless Total Knee Arthroplasty Clinical Trial Eligibility Overview. Trial Name: NCT02839850 — N/A
Osteoarthritis Research Study Groups: ATTUNE Cementless RP TKA
Osteoarthritis Clinical Trial 2023: Cementless Total Knee Arthroplasty Highlights & Side Effects. Trial Name: NCT02839850 — N/A
Cementless Total Knee Arthroplasty 2023 Treatment Timeline for Medical Study. Trial Name: NCT02839850 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT02839850 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many healthcare facilities are executing this experiment in real-world conditions?

"At present, 11 clinical trial sites are accepting participants. These locations are based in Newport News, Lubbock and DeLand as well as 8 other places. To avoid extensive travel commitments, it is recommended to pick the centre closest to you for enrollment purposes."

Answered by AI

Will participants be invited to join this investigation?

"Clinicaltrials.gov indicates that this research has stopped recruiting participants since November 28th 2022, which is when it was last updated. Nevertheless, there are 613 other trials currently accepting patients for enrollment."

Answered by AI

Does the research encompass individuals aged twenty or older?

"This research is restricted to those aged between 22 and 80. There are 30 clinical studies available for minors, while 583 trials target the elderly population."

Answered by AI

Am I able to participate in this medical investigation?

"For this clinical trial, 540 patients aged between 22 and 80 years old with arthrosis are being enrolled. To be included in the study, participants must possess basic literacy skills to comprehend the informed consent document and complete necessary patient reported outcomes (PROs). Furthermore, they must not be bedridden and agree to adhere to all investigational procedures. Lastly, those selected should meet diagnostic criteria for NIDJD as deemed suitable by their investigator for cementless primary TKA surgery involving resurfaced or non-resurfaced patellae."

Answered by AI

Who else is applying?

What state do they live in?
Texas
New York
Florida
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What site did they apply to?
Florida Research Associates
SUNY downstate Medical Center
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Need help, not abel to walk. Looking at treatments for left knee. Right TKR is not great. Functions, have patella Baja clicking and pain around knee cap and back of knee.
PatientReceived 1 prior treatment
~6 spots leftby Jun 2024